Evidence map›Paper›PMID 42318400›Full record

ArticleFrontiers in medicine2026

Vector outcomes after SMILE pro with the VISUMAX 800 for high versus moderate-to-low astigmatism: a contralateral eye comparison.

Yuchen Mei, Yawen Hao, Xuanyu Yang, Aoran Zhang, Ziyuan Tian, Wentian Zhou, Hui Zhang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuchen MeiNanchang Bright Eye Hospital, Nanchang, Jiangxi, China.
Yawen HaoSchool of Ophthalmology and Optometry, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Xuanyu YangSchool of Ophthalmology and Optometry, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Aoran ZhangSchool of Queen Mary, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Ziyuan TianThe Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Wentian ZhouNanchang Bright Eye Hospital, Nanchang, Jiangxi, China.
Hui ZhangNanchang Bright Eye Hospital, Nanchang, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate vector outcomes and higher-order aberrations (HOAs) in eyes with high astigmatism (HA) and their contralateral eyes with moderate-to-low astigmatism (MLA) after small-incision lenticule extraction (SMILE Pro) with automated cyclotorsion compensation. Methods: This single-center retrospective study included 30 patients (60 eyes) who underwent bilateral SMILE Pro using the VISUMAX 800 platform with OcuLign iris registration. The eyes were classified as HA [> 2.00 diopters (D)] or MLA (≤ 2.00 D) according to their preoperative cylinder magnitude. Visual acuity, refractive outcomes, Alpins vector parameters, intraoperative decentration, and HOAs were compared at 6 months after surgery. Results: The mean preoperative manifest cylinder was 2.38 ± 0.25 D in HA eyes and 1.41 ± 0.49 D in MLA eyes. At 6 months, uncorrected distance visual acuity was comparable between eye groups ( Conclusion: In this small retrospective contralateral-eye cohort, SMILE Pro with OcuLign-assisted cyclotorsion compensation showed favorable 6-month visual, refractive, and vector outcomes in eyes with astigmatism slightly above 2.00 D. These findings should be interpreted cautiously given the modest sample size, narrow HA range, and absence of a non-inferiority design.

Indexed as

aberrationAlpins vector analysishigh astigmatismsmall incision lenticule extractionSMILE ProVisuMax 800

Identifiers

PMID42318400
PMCPMC13272052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.